Known targets — ChEMBL curated mechanism
ABL1BMXBRAFBTKCHRNA4CHRNB2CSNK1EEGFRERBB2F10FLT1FLT3FLT4IGF1RINSRITKJAK3KDRKITOPRM1PARP1PARP2PDGFRBPIK3CDRAF1RETSLC18A2TECTXKdacAdacBdacCftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.38 |
| ▸ | ALB | P02768 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | SNCA | P37840 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14940700 | 0.89 | ALDH1A1 (0.43) | NPSR1LMNACA2ALDH1A1TDP1 | |
| SCHEMBL17870952 | 0.86 | NPSR1 (0.41) | CYP1A2NPSR1LMNAPOLBALDH1A1 | |
| SCHEMBL2771666 | 0.77 | MCHR1 (0.43) | CYP1A2CYP2D6CYP3A4ALOX15CYP2C19 | |
| SCHEMBL6667980 | 0.73 | CA2 (0.50) | CYP1A2CYP2D6CYP3A4ALOX15CYP2C19 | |
| Butane SCHEMBL27630383 | 0.71 | GAA (0.52) | CYP1A2CYP2D6CYP3A4CYP2C19LMNA | |
| SCHEMBL30513488 | 0.70 | CYP2D6 (0.50) | CYP1A2CYP2D6CYP3A4ALOX15CYP2C19 | |
| Butane SCHEMBL9425260 | 0.69 | ALDH1A1 (0.50) | CYP1A2CYP2D6CYP3A4CYP2C19LMNA | |
| Propane SCHEMBL3563886 | 0.69 | GAA (0.54) | CYP1A2CYP2D6CYP3A4CYP2C19LMNA | |
| Propane SCHEMBL28408609 | 0.69 | GAA (0.54) | CYP1A2CYP2D6CYP3A4CYP2C19LMNA | |
| Isobutyramide SCHEMBL6491554 | 0.68 | CYP2D6 (0.53) | CYP1A2CYP2D6CYP3A4ALOX15CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015013780-A1 | COMPOSITION COMPRISING AN AMINOSILICONE, A CATIONIC SURFACTANT AND A CATIONIC ASSOCIATIVE POLYMER | L' OREAL (FR) | 2015-02-05 | — | — | WO | disclosed |
| US-20050125912-A1 | Dyeing composition for keratinous fibers comprising an oxyethylene rapeseed fatty acid amide | L'OREAL S.A. (FR) | 2005-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050125912-A1 | Dyeing composition for keratinous fibers comprising an oxyethylene rapeseed fatty acid amide | KRT18, ELOVL5, FADS1 | CYP1A2 186/4885CYP2D6 344/4885CYP3A4 631/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.